Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Chronic Hepatitis B Virus Infection in Zambia
An ongoing clinical trial in Zambia studying chronic hepatitis B virus infection and liver-related conditions (fibrosis, cirrhosis, alcoholi…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Neoadjuvant Therapy of iIparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma [Phase 2]
This Phase 2 clinical trial updates a neoadjuvant combination of iparomlimab, tuvonralimab, and lenvatinib for resectable hepatocellular car…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
This ClinicalTrials.gov update concerns a study in Zambian patients co-infected with HIV and hepatitis B, investigating liver fibrosis and r…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
A prospective population-based cohort study in Zhongshan City comparing hepatocellular carcinoma (HCC) screening strategies is currently rec…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk [NA]
This clinical trial compares ultrasound and abbreviated MRI (with and without hepatobiliary phase) for hepatocellular carcinoma surveillance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC [Phase 2]
A Phase 2 clinical trial is evaluating the combination of photon radiotherapy with tremelimumab and durvalumab for BCLC stage B and C hepato…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO [Phase 3]
A Phase 3 trial is evaluating whether an immune-oncology therapy given every three months after six months of standard administration is as …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
A real-world study to evaluate liver cancer risk in patients with chronic hepatitis B who have a family history of liver cancer, sponsored b…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis
A validation study is planned to evaluate Seravue for diagnosing hepatocellular carcinoma, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: ctDNA Monitoring in Patients With HCC and mCRC [NA]
A recruiting clinical trial from the Medical University of Warsaw is evaluating ctDNA monitoring in patients with hepatocellular carcinoma a…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab [Phase 2]
Phase 2 clinical trial update studying the immune microenvironment in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk [NA]
A clinical trial is evaluating abbreviated MRI using gadoxetic acid versus ultrasonography for surveillance of early-stage hepatocellular ca…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a personalized tumor neoantigen mRNA therapy for advanced hepatocellular carcinoma. The study is current…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC [Phase 1]
Phase 1 clinical trial update for TACE plus Ivonescimab in unresectable non-metastatic hepatocellular carcinoma; the study status is Not Yet…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
A clinical trials.gov update notes a recruiting study evaluating on-treatment surveillance of tumor evolution and response to systemic thera…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial from Zhejiang Cancer Hospital is investigating the combination of hepatic arterial infusion chemotherapy and immu…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma [NA]
A clinical trial is evaluating adjuvant stereotactic body radiation therapy after trans-arterial chemoembolization for unresectable hepatoce…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation
A completed clinical trial evaluated whether PET/CT improves assessment of hepatocellular carcinoma after radiofrequency ablation.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer
A multicenter registry study led by Fudan University to evaluate unresectable stage III hepatocellular carcinoma (CNLC) in liver cancer. The…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere [Phase 3]
A Phase 3 clinical trial in China is evaluating the efficacy, response, and safety of TareSphere for unresectable hepatocellular carcinoma a…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery [NA]
An update on a clinical trial comparing endhole versus pressure-modulated Lipiodol delivery for hepatocellular carcinoma and neuroendocrine …
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: FGF19 Overexpression Combination Unified Study in HCC-19 [Phase 2]
Phase 2 clinical trial investigating a FGF19 overexpression combination for hepatocellular carcinoma, currently recruiting. Sponsor: RenJi H…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC [NA]
This is a clinical trial update on QY-1-T for HBV-associated advanced hepatocellular carcinoma, with the study currently recruiting to evalu…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Ate-Bev Early Response Prediction Model in Advanced HCC
This clinical trial update outlines a study to develop an early response prediction model for advanced hepatocellular carcinoma treated with…